Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study

[1]  G. Aurigemma,et al.  Diastolic heart failure , 2004 .

[2]  S. Jackson.  Diastolic heart failure , 2004, BMJ : British Medical Journal.

[3]  A. Desideri,et al.  Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study , 1990, Cardiovascular Drugs and Therapy.

[4]  D. Brutsaert,et al.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. , 2002, Circulation.

[5]  Harvey Feigenbaum,et al.  Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[6]  R. Belardinelli,et al.  Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. , 2001, European heart journal.

[7]  G. Jackson.  Haemodynamic and metabolic agents in the treatment of stable angina: publication review. , 2001, Coronary artery disease.

[8]  G. Pogátsa.  Metabolic energy metabolism in diabetes: therapeutic implications. , 2001, Coronary artery disease.

[9]  G. Lopaschuk.  Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated? , 2001, Coronary artery disease.

[10]  G. Lopaschuk,et al.  The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. , 2000, Circulation research.

[11]  G. Plosker,et al.  Trimetazidine , 1999, Drugs.

[12]  H. Szwed,et al.  The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1. , 1999, Cardiovascular drugs and therapy.

[13]  S. Chierchia,et al.  Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. , 1998, The American journal of cardiology.

[14]  S. Krishnaswami,et al.  Combination treatment with trimetazidine and diltiazem in stable angina pectoris , 1997, Heart.

[15]  U. Thadani.  Management of patients with chronic stable angina at low risk for serious cardiac events. , 1997, The American journal of cardiology.

[16]  R. Califf,et al.  Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. , 1996, Journal of the American College of Cardiology.

[17]  D. Ardissino,et al.  Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. , 1996, Journal of the American College of Cardiology.

[18]  K. Fox,et al.  Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. , 1996, European heart journal.

[19]  K. Fox,et al.  The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. , 1996, European heart journal.

[20]  R. Bonow.  The hibernating myocardium: implications for management of congestive heart failure. , 1995, The American journal of cardiology.

[21]  R. Kronmal,et al.  Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry). , 1994, The American journal of cardiology.

[22]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.